Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Drug-resistant TB

WHO Recommends Worldwide Adoption Of All Oral-Regimen For MDR/RR-TB

Editor's pick
Health Policy Watch
16 December 2019
Resistance

Drug-resistance or viral-load testing required before switch to dolutegravir in Togo

News
16 December 2019
PrEP science

Facebook ads push misinformation about HIV prevention drugs, LGBT activists say, ‘harming public health’

Editor's pick
Washington Post
10 December 2019
Changing treatment

Lipid increases after switching from TDF to TAF are reversible when treatment is changed back to TDF

News
10 December 2019
Resistance

WHO unveils plan to tackle rising HIV drug resistance in Africa

Editor's pick
World Health Organization
9 December 2019
The search for a cure

Will post-treatment controllers guide us towards an HIV cure?

News
9 December 2019
Pharmaceutical industry

Gilead delayed safer HIV drug to extend monopoly profits, advocates allege

Editor's pick
San Francisco Chronicle
6 December 2019
New & experimental HIV treatments

ViiV Healthcare submits New Drug Application to the FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available

Editor's pick
5 December 2019
Bad science & bogus treatments

China’s CRISPR babies: Read exclusive excerpts from the unseen original research

Editor's pick
MIT Technology Review
4 December 2019
Weight gain & lipodystrophy

New Formulation of Tesamorelin Available for HIV Patients With Lipodystrophy

Editor's pick
Infectious Disease Advisor
4 December 2019
Injectable & long-acting HIV treatment

Effectiveness and frequency of dosing are the most important factors affecting acceptability of injectable HIV therapy, says US study

News
29 November 2019
HIV treatment

Top 10 HIV Clinical Developments of 2019

Editor's pick
TheBodyPro
27 November 2019
Drug interactions & pharmacokinetics

Vigilance over HIV drug interactions still needed

News
26 November 2019
Government, leadership & policy

The World Cannot End HIV Without Continued Innovation

Editor's pick
POZ
25 November 2019
Changing treatment

Caveat emptor: Seven things every patient should know about switching from efavirenz to dolutegravir

Editor's pick
Spotlight
25 November 2019
Treatment interruptions

Second case of unintended HIV transmission during HIV cure study prompts questions about PrEP provision

News
22 November 2019
New & experimental HIV treatments

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention

Editor's pick
ViiV Healthcare press release
21 November 2019
Drug interactions & pharmacokinetics

One-third of people living with HIV in rural Tanzania report clinically relevant drug-drug interactions

News
21 November 2019
Drug interactions & pharmacokinetics

Polypharmacy: What Is It? And How Does It Affect People With HIV?

Editor's pick
TheBodyPro
20 November 2019
Bad science & bogus treatments

Retraction: Questioning the HIV-AIDS hypothesis: 30 years of dissent

Editor's pick
Frontiers in Public Health
18 November 2019
PrEP science

How do we deal with apparent cases of PrEP failure?

News
15 November 2019
PrEP science

96-week results of DISCOVER PrEP trial presented at European AIDS Conference

News
14 November 2019
Treatment simplification strategies

Options for two-drug simplification expand

News
14 November 2019
Kidney problems

Tenofovir (TDF) does not increase risk of kidney disease in people at low risk

News
13 November 2019